Transition of low-grade to high-grade endometrial stromal sarcoma: a case report. 2013

M Kanda, and A Sonoyama, and H Hirano, and T Kizaki, and N Ohara
Department of Obstetrics and Gynecology, Sanda Municipal Hospital, Sanda, Japan. kanda_masatoshi@hospital.sanda.hyogo.jp

BACKGROUND The transition of low-grade endometrial stromal sarcoma (ESS) to high-grade ESS remains a rare clinical event. METHODS A patient presented with abdominal pain and abnormal genital bleeding. She underwent a supracervical hysterectomy with bilateral salpingo-oophorectomy, omentectomy, and resection of peritoneal disseminated lesions. Pathological examination revealed low-grade ESS in the uterus and omentum. Immunohistochemical examination showed immunoreactivity for CD10 and Ki-67 (MIB1) in the uterus and omentum. However, estrogen receptor, progesterone receptor, alpha-SMA, desmin, h-caldesmon, and CAM5-2 were negative. P53 immunoreactivity was noted only in the omental lesion. Despite performing six courses of adjuvant chemotherapy, she recurred in the abdomen. She underwent ileostomy and resection of peritoneal disseminated lesions. Pathology showed high-grade ESS in the recurrent lesion of the ileum, which was characterized by severe cytologic atypia, high mitotic index, multifocal necrosis, increased Ki-67 index, and immunoreactivity for p53. CONCLUSIONS Although rare, the transition of low-grade ESS to high-grade ESS may occur and suggests the worsening of the prognosis. Pathological examination and immunohistochemistry are useful for the diagnosis of the transition of low-grade ESS to high-grade ESS.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016159 Tumor Suppressor Protein p53 Nuclear phosphoprotein encoded by the p53 gene (GENES, P53) whose normal function is to control CELL PROLIFERATION and APOPTOSIS. A mutant or absent p53 protein has been found in LEUKEMIA; OSTEOSARCOMA; LUNG CANCER; and COLORECTAL CANCER. p53 Tumor Suppressor Protein,Cellular Tumor Antigen p53,Oncoprotein p53,TP53 Protein,TRP53 Protein,p53 Antigen,pp53 Phosphoprotein,Phosphoprotein, pp53
D016889 Endometrial Neoplasms Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells. Cancer of Endometrium,Endometrial Cancer,Endometrial Carcinoma,Cancer of the Endometrium,Carcinoma of Endometrium,Endometrium Cancer,Neoplasms, Endometrial,Cancer, Endometrial,Cancer, Endometrium,Cancers, Endometrial,Cancers, Endometrium,Carcinoma, Endometrial,Carcinomas, Endometrial,Endometrial Cancers,Endometrial Carcinomas,Endometrial Neoplasm,Endometrium Cancers,Endometrium Carcinoma,Endometrium Carcinomas,Neoplasm, Endometrial
D060787 Neoplasm Grading Methods which attempt to express in replicable terms the level of CELL DIFFERENTIATION in neoplasms as increasing ANAPLASIA correlates with the aggressiveness of the neoplasm. Gleason Grading,Gleason Score,Tumor Grading,Grading, Gleason,Grading, Neoplasm,Grading, Tumor,Score, Gleason
D018203 Sarcoma, Endometrial Stromal A highly malignant subset of neoplasms arising from the endometrial stroma. Tumors in this group infiltrate the stroma with a wide range of atypia cells and numerous mitoses. They are capable of widespread metastases (NEOPLASM METASTASIS). Endometrial Stromal Sarcoma,Endometrial Stromal Sarcomas,Sarcomas, Endometrial Stromal,Stromal Sarcoma, Endometrial,Stromal Sarcomas, Endometrial

Related Publications

M Kanda, and A Sonoyama, and H Hirano, and T Kizaki, and N Ohara
July 2010, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists,
M Kanda, and A Sonoyama, and H Hirano, and T Kizaki, and N Ohara
January 2015, Iranian journal of medical sciences,
M Kanda, and A Sonoyama, and H Hirano, and T Kizaki, and N Ohara
December 2006, Gynecologic oncology,
M Kanda, and A Sonoyama, and H Hirano, and T Kizaki, and N Ohara
May 2023, International journal of surgery case reports,
M Kanda, and A Sonoyama, and H Hirano, and T Kizaki, and N Ohara
August 2021, Journal of medical case reports,
M Kanda, and A Sonoyama, and H Hirano, and T Kizaki, and N Ohara
November 2023, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists,
M Kanda, and A Sonoyama, and H Hirano, and T Kizaki, and N Ohara
May 2024, Radiology case reports,
M Kanda, and A Sonoyama, and H Hirano, and T Kizaki, and N Ohara
August 2019, Zhonghua bing li xue za zhi = Chinese journal of pathology,
M Kanda, and A Sonoyama, and H Hirano, and T Kizaki, and N Ohara
January 2007, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society,
M Kanda, and A Sonoyama, and H Hirano, and T Kizaki, and N Ohara
December 2005, Zhonghua bing li xue za zhi = Chinese journal of pathology,
Copied contents to your clipboard!